Reuters logo
BRIEF-Kite Pharma announces successful defense of Roberts patent, intent to appeal to U.S. Patent and Trademark Office decision on a narrow patent focused on select CD28 CAR-T products
December 19, 2016 / 1:41 PM / a year ago

BRIEF-Kite Pharma announces successful defense of Roberts patent, intent to appeal to U.S. Patent and Trademark Office decision on a narrow patent focused on select CD28 CAR-T products

Dec 19 (Reuters) - Kite Pharma Inc :

* Kite Pharma announces successful defense of Roberts patent and intent to appeal U.S. Patent and trademark office decision on a narrow patent focused on select CD28 CAR-T products Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below